Executive Summary
A single $162M VA IT contract to Planned Systems International Inc signals bullish revenue potential through 2025-06-13, with base + options reaching $164M via Time & Materials structure reducing execution risk. Low $7.2M outlay to date highlights early-stage execution dependency on option exercises amid T&M audit vulnerabilities. Minority-owned IT firms demonstrate competitive edge in open VA procurements, warranting sector monitoring.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal IT & Cybersecurity Contracts digest from February 27, 2026.
Investment Signals (1)
- $162M VA Enterprise Testing Contract (HIGH)▲
Planned Systems International Inc secured $162M obligation (up to $164M with options) for multi-year IT services, awarded via full/open competition despite minority-owned status.
Risk Flags (2)
- Execution [HIGH RISK]▼
Low $7.2M outlay vs $162M obligation risks deobligation; performance extends to 2025 only if options exercised beyond passed 2021 end date.
- Regulatory [MEDIUM RISK]▼
Time & Materials contract exposed to government audits on labor rates and costs.
Opportunities (1)
- ◆
$1.8M unexercised options plus multi-year IT testing support in Bay Pines, FL.
Sector Themes (1)
- ◆
$162M award under NAICS 541511 underscores sustained federal demand for enterprise IT testing via Delivery Orders.
Watch List (1)
- 👁
{"entity"=>"Planned Systems International Inc", "reason"=>"Dominates period with $162M obligation; minority status enables open wins with low outlay signaling upside.", "trigger"=>"Outlay >20% of obligation or option exercises"}
Get daily alerts with 1 investment signals, 2 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal IT & Cybersecurity Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals